CDC.gov As of December 27, 2019, there have been 2,561 hospitalized cases of lung injury or deaths, associated with the use of e-cigarettes and vaping products reported from all 50 states, the District of Columbia, Puerto Rico and the US Virgin Islands. 55 Deaths were confirmed in 27 states and DC.
No state has gone unaffected by this e-cigarette and vaping outbreak.
Emergency department visits suggest that the outbreak of EVALI or e-cigarette, or vaping product use-associated lung injury, began in June of 2019. Cases have been declining since a peak in September., but have yet to go to levels previously seen before June and remain a constant concern.
Laboratory data support previous findings that vitamin e acetate is closely associated with EVALI.
- The study analyzed samples from 51 EVALI cases from 16 states and a comparison group of samples from 99 healthier people for vitamin E acetate, plant oils, medium-chain triglyceride(MCT)oil, coconut oil, petroleum distillates, and diluent terpenes.
- Vitamin E acetate was identified in bronchoalveolar lavage(BAL) fluid samples (fluid samples from the lungs) from 48 of the 51 EVALI patients, but not in the BAL fluid from the healthy comparison group.
National data shows that certain groups of EVALI patients released from the hospital are more likely to be rehospitalized or die.